Literature DB >> 16489644

Favorable outcomes of hilar duct oriented hepatic resection for high grade Tsunoda type hepatolithiasis.

Bong-Wan Kim1, Hee-Jung Wang, Wook-Hwan Kim, Myung-Wook Kim.   

Abstract

AIM: To evaluate the efficacy of hilar duct oriented hepatectomy for intractable hepatolithiasis, the ventral hilum exposure (VHE) method that has been applied by the authors.
METHODS: From June 1994 to June 2004 for a period of 10 years, 153 patients who had Tsunoda type III or IV hepatolithiasis, received hepatectomy at our institution. Among these patients, 128 who underwent hepatectomy by the VHE method were the subjects for the study. We analyzed the risk of this procedure, residual rate of intra-hepatic stones, and stone recurrent rates.
RESULTS: The average age was 54.2 years, and the male to female ratio was 1:1.7. The average follow-up period was 25.6 mo (6-114 mo). There was no post-operative severe complication or mortality after the operation. The rate of residual stones was 5.4% and the rate of recurrent stones was 4.2%.
CONCLUSION: VHE is a safe surgical procedure and provides favorable treatment results of intractable hepatolithiasis. Especially, this procedure has advantage in that intra-hepatic bile duct stricture may be confirmed and corrected directly during surgery.

Entities:  

Mesh:

Year:  2006        PMID: 16489644      PMCID: PMC4066063          DOI: 10.3748/wjg.v12.i3.431

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  25 in total

1.  Long-term results of hepaticojejunostomy for hepatolithiasis.

Authors:  T Kusano; T T Isa; Y Muto; M Otsubo; T Yasaka; M Furukawa
Journal:  Am Surg       Date:  2001-05       Impact factor: 0.688

2.  Configuration of the right portion of the caudate lobe with special reference to identification of its right margin.

Authors:  S Kitagawa; G Murakami; F Hata; K Hirata
Journal:  Clin Anat       Date:  2000       Impact factor: 2.414

3.  Location of the ventral margin of the paracaval portion of the caudate lobe of the human liver with special reference to the configuration of hepatic portal vein branches.

Authors:  Daehyun Kwon; Gen Murakami; Fumitake Hata; Hee Jung Wang; Min Suk Chung; Koichi Hirata
Journal:  Clin Anat       Date:  2002-11       Impact factor: 2.414

4.  Experience with percutaneous transhepatic cholangioscopy (PTCS) in the management of biliary tract disease.

Authors:  T Simon; A S Fink; A M Zuckerman
Journal:  Surg Endosc       Date:  1999-12       Impact factor: 4.584

5.  Indication and procedure for treatment of hepatolithiasis.

Authors:  Kazuhisa Uchiyama; Hironobu Onishi; Masaji Tani; Hiroyuki Kinoshita; Masaki Ueno; Hiroki Yamaue
Journal:  Arch Surg       Date:  2002-02

6.  Factors predicting concurrent cholangiocarcinomas associated with hepatolithiasis.

Authors:  Y-T Kim; J S Byun; J Kim; Y H Jang; W J Lee; J K Ryu; S W Kim; Y B Yoon; C Y Kim
Journal:  Hepatogastroenterology       Date:  2003 Jan-Feb

7.  Percutaneous choledochoscopic treatment of intrahepatic stones, including management of associated biliary stenoses.

Authors:  I Maetani; J Ishiguro; S Ogawa; M Sato; Y Igarashi; Y Sakai
Journal:  Endoscopy       Date:  1999-08       Impact factor: 10.093

8.  Cholangiocellular carcinoma depending on the kind of intrahepatic calculi in patients with hepatolithiasis.

Authors:  Kazuo Chijiiwa; Kazuhiro Ohtani; Hirokazu Noshiro; Toru Yamasaki; Shuji Shimizu; Koji Yamaguchi; Masao Tanaka
Journal:  Hepatogastroenterology       Date:  2002 Jan-Feb

9.  Percutaneous transhepatic choledochoscopic removal of intrahepatic stones.

Authors:  M-T Cheung; S-H Wai; P C-H Kwok
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

10.  Changing patterns of gallstone disease in Korea.

Authors:  Yong-Hyun Park; Sang-Jae Park; Jin-Young Jang; Young Joon Ahn; Youn-Chan Park; Yong Bum Yoon; Sun-Whe Kim
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

View more
  8 in total

1.  Bilateral liver resection for bilateral intrahepatic stones.

Authors:  Shao-Qiang Li; Li-Jian Liang; Yun-Peng Hua; Bao-Gang Peng; Dong Chen; Shun-Jun Fu
Journal:  World J Gastroenterol       Date:  2009-08-07       Impact factor: 5.742

2.  Surgical management of hepatolithiasis.

Authors:  Sujit Vijay Sakpal; Nitin Babel; Ronald Scott Chamberlain
Journal:  HPB (Oxford)       Date:  2009-05       Impact factor: 3.647

Review 3.  Classification and management of hepatolithiasis: A high-volume, single-center's experience.

Authors:  Xiaobin Feng; Shuguo Zheng; Feng Xia; Kuansheng Ma; Shuguang Wang; Ping Bie; Jiahong Dong
Journal:  Intractable Rare Dis Res       Date:  2012-11

4.  Liver Resection for Primary Intrahepatic Stones: Focus on Postoperative Infectious Complications.

Authors:  Gennaro Clemente; Agostino M De Rose; Rita Murri; Francesco Ardito; Gennaro Nuzzo; Felice Giuliante
Journal:  World J Surg       Date:  2016-02       Impact factor: 3.352

5.  Treatment of chronic proliferative cholangitis with c-myc shRNA.

Authors:  Fu-Yu Li; Nan-Sheng Cheng; Jing-Qiu Cheng; Hui Mao; Li-Sheng Jiang; Ning Li; Sheng He
Journal:  World J Gastroenterol       Date:  2009-01-07       Impact factor: 5.742

6.  Risk factors for long-term outcomes after initial treatment in hepatolithiasis.

Authors:  Jin-Seok Park; Seok Jeong; Don Haeng Lee; Byoung Wook Bang; Jung Il Lee; Jin-Woo Lee; Kye Sook Kwon; Hyung Kil Kim; Yong Woon Shin; Young Soo Kim; Shin Goo Park
Journal:  J Korean Med Sci       Date:  2013-10-31       Impact factor: 2.153

7.  Variation or newly identified glissonian pedicles between the lateral and medial sections of the liver, using cadaver dissection.

Authors:  In-Gyu Kim; Weiguang Xu; Hee-Jung Wang; Yong-Keun Park; Bong-Wan Kim
Journal:  J Korean Surg Soc       Date:  2013-11-26

8.  Comparison Between Percutaneous Transhepatic Rigid Cholangioscopic Lithotripsy and Conventional Percutaneous Transhepatic Cholangioscopic Surgery for Hepatolithiasis Treatment.

Authors:  Ping Wang; Beiwang Sun; Binyuan Huang; Jiafen Xie; Yanmin Liu; Canhua Zhu; Chen Ye; Zixuan Zhou
Journal:  Surg Laparosc Endosc Percutan Tech       Date:  2016-02       Impact factor: 1.719

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.